Vagus nerve stimulation (VNS) for treatment-resistant depressions

A multicenter study

A. John Rush, Mark S. George, Harold A. Sackeim, Lauren B. Marangell, Mustafa M. Husain, Cole A. Giller, Ziad Nahas, Stephen Haines, Richard K. Simpson, Robert Goodman

Research output: Contribution to journalArticle

433 Citations (Scopus)

Abstract

Background: Vagus Nerve Stimulation (VNS) delivered by the NeuroCybernetic Prosthesis (NCP) System was examined for its potential antidepressant effects. Methods: Adult outpatients (n = 30) with nonpsychotic, treatment-resistant major depressive (n = 21) or bipolar I (n = 4) or II (n = 5; depressed phase) disorders who had failed at least two robust medication trials in the current major depressive episode (MDE) while on stable medication regimens completed a baseline period followed by NCP System implantation. A 2-week, single-blind recovery period (no stimulation) was followed by 10 weeks of VNS. Results: In the current MDE (median length = 4.7 years), patients had not adequately responded to two (n = 9), three (n = 2), four (n = 6), or five or more (n = 13) robust antidepressant medication trials or electroconvulsive therapy (n = 17). Baseline 28-item Hamilton Depression Rating Scale (HDRS28) scores averaged 38.0. Response rates (≥50% reduction in baseline scores) were 40% for both the HDRS28 and the Clinical Global Impressions - Improvement index (score of 1 or 2) and 50% for the Montgomery-Asberg Depression Rating Scale. Symptomatic responses (accompanied by substantial functional improvement) have been largely sustained during long-term follow-up to date. Conclusions: These open trial results suggest that VNS has antidepressant effects in treatment-resistant depressions. (C) 2000 Society of Biological Psychiatry.

Original languageEnglish (US)
Pages (from-to)276-286
Number of pages11
JournalBiological Psychiatry
Volume47
Issue number4
DOIs
StatePublished - Feb 15 2000
Externally publishedYes

Fingerprint

Treatment-Resistant Depressive Disorder
Vagus Nerve Stimulation
Antidepressive Agents
Multicenter Studies
Prosthesis Implantation
Depression
Electroconvulsive Therapy
Prostheses and Implants
Outpatients
Therapeutics

Keywords

  • Bipolar disorder
  • Electrical stimulation
  • Treatment-resistant depression
  • Vagus Nerve Stimulation (VNS)

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Rush, A. J., George, M. S., Sackeim, H. A., Marangell, L. B., Husain, M. M., Giller, C. A., ... Goodman, R. (2000). Vagus nerve stimulation (VNS) for treatment-resistant depressions: A multicenter study. Biological Psychiatry, 47(4), 276-286. https://doi.org/10.1016/S0006-3223(99)00304-2

Vagus nerve stimulation (VNS) for treatment-resistant depressions : A multicenter study. / Rush, A. John; George, Mark S.; Sackeim, Harold A.; Marangell, Lauren B.; Husain, Mustafa M.; Giller, Cole A.; Nahas, Ziad; Haines, Stephen; Simpson, Richard K.; Goodman, Robert.

In: Biological Psychiatry, Vol. 47, No. 4, 15.02.2000, p. 276-286.

Research output: Contribution to journalArticle

Rush, AJ, George, MS, Sackeim, HA, Marangell, LB, Husain, MM, Giller, CA, Nahas, Z, Haines, S, Simpson, RK & Goodman, R 2000, 'Vagus nerve stimulation (VNS) for treatment-resistant depressions: A multicenter study', Biological Psychiatry, vol. 47, no. 4, pp. 276-286. https://doi.org/10.1016/S0006-3223(99)00304-2
Rush AJ, George MS, Sackeim HA, Marangell LB, Husain MM, Giller CA et al. Vagus nerve stimulation (VNS) for treatment-resistant depressions: A multicenter study. Biological Psychiatry. 2000 Feb 15;47(4):276-286. https://doi.org/10.1016/S0006-3223(99)00304-2
Rush, A. John ; George, Mark S. ; Sackeim, Harold A. ; Marangell, Lauren B. ; Husain, Mustafa M. ; Giller, Cole A. ; Nahas, Ziad ; Haines, Stephen ; Simpson, Richard K. ; Goodman, Robert. / Vagus nerve stimulation (VNS) for treatment-resistant depressions : A multicenter study. In: Biological Psychiatry. 2000 ; Vol. 47, No. 4. pp. 276-286.
@article{af6735749ecf43f3b43c6c6ea64df4e6,
title = "Vagus nerve stimulation (VNS) for treatment-resistant depressions: A multicenter study",
abstract = "Background: Vagus Nerve Stimulation (VNS) delivered by the NeuroCybernetic Prosthesis (NCP) System was examined for its potential antidepressant effects. Methods: Adult outpatients (n = 30) with nonpsychotic, treatment-resistant major depressive (n = 21) or bipolar I (n = 4) or II (n = 5; depressed phase) disorders who had failed at least two robust medication trials in the current major depressive episode (MDE) while on stable medication regimens completed a baseline period followed by NCP System implantation. A 2-week, single-blind recovery period (no stimulation) was followed by 10 weeks of VNS. Results: In the current MDE (median length = 4.7 years), patients had not adequately responded to two (n = 9), three (n = 2), four (n = 6), or five or more (n = 13) robust antidepressant medication trials or electroconvulsive therapy (n = 17). Baseline 28-item Hamilton Depression Rating Scale (HDRS28) scores averaged 38.0. Response rates (≥50{\%} reduction in baseline scores) were 40{\%} for both the HDRS28 and the Clinical Global Impressions - Improvement index (score of 1 or 2) and 50{\%} for the Montgomery-Asberg Depression Rating Scale. Symptomatic responses (accompanied by substantial functional improvement) have been largely sustained during long-term follow-up to date. Conclusions: These open trial results suggest that VNS has antidepressant effects in treatment-resistant depressions. (C) 2000 Society of Biological Psychiatry.",
keywords = "Bipolar disorder, Electrical stimulation, Treatment-resistant depression, Vagus Nerve Stimulation (VNS)",
author = "Rush, {A. John} and George, {Mark S.} and Sackeim, {Harold A.} and Marangell, {Lauren B.} and Husain, {Mustafa M.} and Giller, {Cole A.} and Ziad Nahas and Stephen Haines and Simpson, {Richard K.} and Robert Goodman",
year = "2000",
month = "2",
day = "15",
doi = "10.1016/S0006-3223(99)00304-2",
language = "English (US)",
volume = "47",
pages = "276--286",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Vagus nerve stimulation (VNS) for treatment-resistant depressions

T2 - A multicenter study

AU - Rush, A. John

AU - George, Mark S.

AU - Sackeim, Harold A.

AU - Marangell, Lauren B.

AU - Husain, Mustafa M.

AU - Giller, Cole A.

AU - Nahas, Ziad

AU - Haines, Stephen

AU - Simpson, Richard K.

AU - Goodman, Robert

PY - 2000/2/15

Y1 - 2000/2/15

N2 - Background: Vagus Nerve Stimulation (VNS) delivered by the NeuroCybernetic Prosthesis (NCP) System was examined for its potential antidepressant effects. Methods: Adult outpatients (n = 30) with nonpsychotic, treatment-resistant major depressive (n = 21) or bipolar I (n = 4) or II (n = 5; depressed phase) disorders who had failed at least two robust medication trials in the current major depressive episode (MDE) while on stable medication regimens completed a baseline period followed by NCP System implantation. A 2-week, single-blind recovery period (no stimulation) was followed by 10 weeks of VNS. Results: In the current MDE (median length = 4.7 years), patients had not adequately responded to two (n = 9), three (n = 2), four (n = 6), or five or more (n = 13) robust antidepressant medication trials or electroconvulsive therapy (n = 17). Baseline 28-item Hamilton Depression Rating Scale (HDRS28) scores averaged 38.0. Response rates (≥50% reduction in baseline scores) were 40% for both the HDRS28 and the Clinical Global Impressions - Improvement index (score of 1 or 2) and 50% for the Montgomery-Asberg Depression Rating Scale. Symptomatic responses (accompanied by substantial functional improvement) have been largely sustained during long-term follow-up to date. Conclusions: These open trial results suggest that VNS has antidepressant effects in treatment-resistant depressions. (C) 2000 Society of Biological Psychiatry.

AB - Background: Vagus Nerve Stimulation (VNS) delivered by the NeuroCybernetic Prosthesis (NCP) System was examined for its potential antidepressant effects. Methods: Adult outpatients (n = 30) with nonpsychotic, treatment-resistant major depressive (n = 21) or bipolar I (n = 4) or II (n = 5; depressed phase) disorders who had failed at least two robust medication trials in the current major depressive episode (MDE) while on stable medication regimens completed a baseline period followed by NCP System implantation. A 2-week, single-blind recovery period (no stimulation) was followed by 10 weeks of VNS. Results: In the current MDE (median length = 4.7 years), patients had not adequately responded to two (n = 9), three (n = 2), four (n = 6), or five or more (n = 13) robust antidepressant medication trials or electroconvulsive therapy (n = 17). Baseline 28-item Hamilton Depression Rating Scale (HDRS28) scores averaged 38.0. Response rates (≥50% reduction in baseline scores) were 40% for both the HDRS28 and the Clinical Global Impressions - Improvement index (score of 1 or 2) and 50% for the Montgomery-Asberg Depression Rating Scale. Symptomatic responses (accompanied by substantial functional improvement) have been largely sustained during long-term follow-up to date. Conclusions: These open trial results suggest that VNS has antidepressant effects in treatment-resistant depressions. (C) 2000 Society of Biological Psychiatry.

KW - Bipolar disorder

KW - Electrical stimulation

KW - Treatment-resistant depression

KW - Vagus Nerve Stimulation (VNS)

UR - http://www.scopus.com/inward/record.url?scp=0033961645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033961645&partnerID=8YFLogxK

U2 - 10.1016/S0006-3223(99)00304-2

DO - 10.1016/S0006-3223(99)00304-2

M3 - Article

VL - 47

SP - 276

EP - 286

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 4

ER -